Patricia Maiso

Santander, CB, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Feasibility and Interim Safety and Efficacy Analysis of a Fast Automated Production of Prophylactic Cytomegalovirus-Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation.

Feasibility and Interim Safety and Efficacy Analysis of a Fast Automated Production of Prophylactic Cytomegalovirus-Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: May 30, 2026

Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia.

Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 16, 2024

Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia.

Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 16, 2024

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.

Journal: Cancers

Published: April 24, 2021

Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment.

Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment.

Journal: Haematologica

Published: October 15, 2020

Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.

Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.

Journal: Blood

Published: December 20, 2019

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Journal: Leukemia

Published: May 02, 2019

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.

The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 22, 2018

Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.

Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.

Journal: Current osteoporosis reports

Published: September 11, 2017

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes.

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes.

Journal: Oncoimmunology

Published: January 10, 2017

Biological Insights into Myeloma and Other B Cell Malignancies.

Biological Insights into Myeloma and Other B Cell Malignancies.

Journal: BioMed research international

Published: January 19, 2016

Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.

Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.

Journal: Blood

Published: August 20, 2015

Showing 1-12 of 27

Last Updated: 09/26/2026